Serum Institute of India has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines
British cell therapy firm makes announcement.
Poonawalla said easing the export restrictions is a government of India's decision, and he will go by what the Centre feels is appropriate
Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about $4.9 billion
Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday.
India will allow entry of this vaccine once the USFDA approves it
Serum Institute has disassociated itself from its executive director's statement that govt began the Covid vaccination of multiple age groups without taking into consideration the available stock
Company says it never exported vaccines at the cost of the people of India
India's self-sufficiency in vaccine production was destroyed one and half decades ago under the UPA-I government, by moving vaccine manufacture and government procurement to the private sector
To this, the SII said they are doing their best to meet countrywide vaccine requirements.
Adar Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July
Free, universal access to inoculation could prepare India better for a third Covid-19 resurgence.
'We have always stood in solidarity with our friends and our partners in India,' says State Department.
Coronavirus live updates: Bharat Biotech sets price for its Covaxin vaccine; Serum Institute defends the cost of its Covishield shot in the market.
Serum Institute says Biden administration is blocking exports of raw materials that it needs to make Covid-19 vaccines.
Regulatory uncertainty, bullying, and contempt for legitimate profit-making is familiar to every entrepreneur in India.
A million doses from the Indian company already delivered have been sold on to other countries in the African Union.
This comes after govt panel visits facilities of SII and Bharat Biotech
The petitioner, 41-year old Asif Riaz, also sought an interim injunction restraining the Central government and the Drugs Controller General of India from continuing with administering Covishield
Cairn Energy has filed a case in a US district court to enforce a $1.2 billion arbitration award it won in a tax dispute against India, a court document showed. Read top news with Business Standard